TrialBreast cancer research and treatment2013

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA).

David Miles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.